Sun Pharmaceutical Industries is currently trading at Rs. 464.50, up by 2.40 points or 0.52% from its previous closing of Rs. 462.10 on the BSE.

The scrip opened at Rs. 458.00 and has touched a high and low of Rs. 465.65 and Rs. 455.55 respectively. So far 131786 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 678.80 on 06-Sep-2018 and a 52 week low of Rs. 375.40 on 18-Jan-2019.

Last one week high and low of the scrip stood at Rs. 473.70 and Rs. 455.55 respectively. The current market cap of the company is Rs. 111293.15 crore.

The promoters holding in the company stood at 54.38%, while Institutions and Non-Institutions held 32.53% and 13.09% respectively.

Sun Pharmaceutical Industries’ wholly owned subsidiary -- Sun Pharma Distributors will commence distributing its formulation products in India from this month in a phased manner on the same terms as was with Aditya Medisales. This phased transition is expected to be fully completed by the first quarter of 2019-20.

In January, the company had announced that distribution related to the company's India domestic formulations business shall be transitioned from Aditya Medisales to its wholly-owned subsidiary.

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.

Sun Pharma Inds. Share Price

1779.30 -3.50 (-0.20%)
17-Dec-2025 11:37 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1779.30
Dr. Reddys Lab 1276.00
Cipla 1493.60
Zydus Lifesciences 917.00
Lupin 2116.15
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×